A DIGITAL PILL FOR THE MIND

Inner Cosmos is a neurotechnology company. We are building “TMS-To-Go,” a brain-computer interface to treat depression.

MOOD DISORDERS ARE PERSONAL

Mood disorders are debilitating. Depression deprives over 200 million people worldwide of their potential, locking them in a state of constant struggle and exhaustion. Sufferers live in a perpetual state of distraction, balancing the everyday challenges of life with an invisible burden. 

At Inner Cosmos, we are building our system for individuals diagnosed with treatment-resistant depression. These individuals are hit hardest and have the greatest need for a revolutionary solution.

THE DIGITAL PILL

THE NEXT NATURAL EVOLUTION OF MEDICINE

The “Digital Pill” is a personalized neurotechnology solution that reharmonizes the mind using responsive neural stimulation that is tuned to each individual user. Discover your limitless potential—discover your very own inner cosmos.

Greater accuracy

The Digital Pill offers higher efficacy than pharmaceuticals of the past and without the side effects.

Greater accessibility

The Digital Pill offers superior accessibility than BCIs of the past—no invasive risks, no external headsets. 

OUR MISSION

The next natural evolution of medicine starts with a new age of precision pharma. We built a brain chip that works the way our brain thinks, enabling freedom from depression, freedom to be yourself. We are bringing humanity back to balance.

MEET THE CREATORS

Meron Gribetz

CEO

Co-Founder

The co-inventor of first - and top-rated - augmented reality glasses, raised $130M, product leader

Dr Eric Leuthardt

Chief Medical Officer

Co-Founder

World leading neurosurgeon, pioneer in laser neurosurgery, co-inventor of ECoG (the second leading invasive brain-computer interface)

Dr Dan Moran

VP of Hardware

Co-Founder

Leading primatologist, expert in bioelectric feedback phenomena, co-inventor of ECoG

Ted Kucklick

Head of Product

Co-founder

Serial medical tech entrepreneur, the author of "The Medical Device R&D Handbook," conducted several successful health company M&As

Dr Ed Boyden

Head of Advisory

Pioneer of one of the most advanced neurotechnologies - optogenetics - and several other breakthrough technologies for imaging and interfacing with the brain

Dr Yvette Dzumaga

Head of Partnerships

MD in psychiatry with MBA background, field experience with depression and suicidality in ECT, TMS, inpatient and outpatient settings

Dr Susan Alpert

Chief Regulatory Officer

Previous Head of Regulatory at Medtronic, Director of Office of Device Evaluations at FDA

Jesse Wheeler

VP Product

Expert operational manager with 16+ years of experience in the medical device industry, across several successful exits

BE A PART OF THE JOURNEY

Contact us for more details